Skip to content
FIND A HEALTH VALLEY ACTOR

News

If you would like your news to be listed here, please fill in the form to upload your information. Please note, we will only post news related to the life sciences.

Latest BioAlps news

On this page you will find all the latest news regarding BioAlps affiliated members and life sciences activities in western Switzerland.

All the latest press articles featuring BioAlps can be found in our Media Center on our About page.

OramaVR

A VR training programme for medical students supported by Innosuisse

Viva VOsCE is a revolutionary project aiming at transforming medical education through harnessing the power of Virtual Reality (VR) technology….

FIF 2023

Three new projects financed in Geneva by the FIF

Plair, Endotelix and Dr Beat Walpoth received funding from the Fongit Innovation Fund (FIF).   Plair SA: Growth loan of…

Senbiosys

Senbiosys raises more than CHF 600,000 on kickstarter

Senbiosys developed a smart ring and an application to give users inputs about their health and wellness. The EPFL spin-off…

Tech4Eva 2023

Tech4Eva selected 16 projects for its 2023 programme

16 projects have been selected for the 2023 programme   Tech4Eva is an EPFL Innovation Park and Groupe Mutuel initiative…

Debiopharm Innovation Fund

Debiopharm and Merck invest in artificial intelligence

Debiopharm Innovation Fund, the strategic investment arm of Swiss biopharmaceutical company Debiopharm, and M Ventures, the strategic, corporate venture capital…

Medyria

EFI-Lake Geneva Ventures and Yellowstone Holding AG invest CHF 3,5 million in Medyria

Medyria’s PyCath aims to be the only device on the market with pressure and blood flow velocity sensing for the…

Sophia Genetics / Agilent

SOPHiA GENETICS and Agilent Partner

SOPHiA GENETICS, a Lausanne-based cloud-native software company in the healthcare space and the leader in data-driven medicine, is partnering with…

Bearmind

Bearmind raises CHF 1,3 million

The startup develops sensors and algorithms to provide a real-time assessment of the risk of concussion for professional athletes.  …

GeNeuro

GeNeuro raises €25 million for its treatment against long COVID

GeNeuro develops timelimab, an antibody that showed promising results in treating inflammatory symptoms for long COVID patients   GeNeuro, a…

DayOne Tech Jura

Three Jura start-ups awarded with the DayOne Tech accelerator prize 

The Jura branch of the Swiss Innovation Park Basel Area is home to 28 companies and institutions, including ten in…

Debiopharm

Debiopharm expands its oncology pipeline

The Lausanne-based biotech company has obtained global rights from a Novo Nordisk molecule and plans to take the compound forward…

Raphaël Conz

Raphaël Conz is the New Head of Department for Economic Promotion and Innovation in the canton of Vaud

Raphaël Conz is also BioAlps’ vice-president. For many years, he has worked to promote the attractiveness and the reputation of…

Medistri

Medistri invests CHF 8 million in Domdidier

The largest independent sterilisation company in Europe invests to expand its plant in Domdidier, in the canton of Fribourg.  …

Oculis

Oculis Announces US public listing on Nasdaq

A Swiss Health Valley success story! Oculis goes public.   Oculis Holding AG (“Oculis”), based at EPFL Innovation Park in…

Comphya

Comphya receives approval for first pilot clinical trial in Australia

A swissmade neuromodulator to treat erectile dysfunction starts clinical trials in Australia   Comphya SA, developer of the first neuromodulator…

Fluosphera

FluoSphera Secures a Pre-Seed Investment of $ 1M 

The US accelerator IndieBio New York which is part of SOSV, Swiss-based Mountain Labs, and EFI Lake Geneva Ventures participated…

Lunaphore

Lunaphore and CRO Sirona Dx collaborate to expand COMET™ offerings to US-based biotech and biopharma customers

Sirona Dx will become the first US-based Contract Research Organization (CRO) to offer Lunaphore’s flagship COMET™ spatial biology platform as a service….

Fondation Leenaards

Leenaards Foundation 2023 Science Prizes

Leenaards Foundation announces three winners of the 2023 Science Prizes. CHF 1.5 million are awarded to support biomedical research in…

Obseva

ObsEva Announces Strategic Reorganization to Consolidate Operations in Switzerland

In financial trouble, the Geneva-based femtech company had to lay off its employees and reorganize its management   Obseva, in…

Terapet

Terapet raises CHF 2,3 million

The Swiss MedTech company is developing next generation imaging technology, and closed a Pre-Series A investment round. This funding supports…

De Vigier Awards

50 startups selected for the W.A. de Vigier Awards pitch day

February 23 is Selection Day, where the young companies pitch their ideas in front of the Foundation Board, investors, selected…

MimiX - Precomb

mimiX Biotherapeutics and PreComb join forces to fight cancer

 The two companies are partnering to accelerate the process of personalized cancer drug profiling leveraging the potential of both company’s…

Mindmaze

Izar by Mindmaze, a new smart device to improve hand rehabilitation

MindMaze, a global pioneer in the development of AI-driven digital neurotherapeutics, is proud to announce the US and EU launch…

Future of Health

7 digital health start-ups selected by the Future of Health Grant

CSS and EPFL announce the 2nd cohort of the Future of Health Program   The Future of Health Grant (FoHG)…

SEED BIOSCIENCE

SEED Biosciences teams up with Molecular Device to market its DispenCell

Biopôle-based SEED Biosciences teams up with Molecular Devices, LLC. The American leading provider of high-performance life science solutions is now…

MintWorld

Lonza wants to encourage careers In Life Sciences and opens MINTWorld

Faced with a shortage of qualified personnel in the field of mathematics, computer science, natural sciences and technology (MINT) in…

Gene Predictis

Gene Predictis is bought by NIMGenetics

The EPFL-based start-up accepted the offer of the Spanish company. The amount of the transaction has not been disclosed.  …

Sofia Genetics

SOPHiA GENETICS Expands Partnership with AstraZeneca

The Swiss start-up, specialised in AI assisted medicine, and the Swedish-British pharmaceutical company want to create multimodal approaches for cancer drug…

13 Biotech to watch

13 biotech companies to watch according to BioAlps and Labiotech.eu

BioAlps recently collaborated with Labiotech.eu to detect the 13 biotech and healthtech companies in the Swiss Health Valley to watch…

Hopital La Tour

La Tour invests CHF 750 million in a health campus in Meyrin

Hôpital de La Tour in Geneva sells its premises to finance an ambitious innovation-oriented health campus   The owners of…

AC Immune MJFOX

CHF 500 000 for AC Immune

Michael J. Fox Foundation for Parkinson’s Research (MJFF) and Target ALS Foundation (Target ALS) provide more than USD 500,000 in…

Aspivix

Aspivix receives U.S. FDA Clearance for Carevix™, Their Novel Cervical Stabilizer

Carevix™, a novel atraumatic cervical stabilizer created by the Swiss startup ASPIVIX SA, received 510(k) clearance from the U.S. Food…

Biopôle Startup Fund winners 2022

Volumina Medical, Parithera and PeriVision win the Biopôle Startup Fund 2022

The initiative, which includes up to CHF 90,000 of support per year for up to three consecutive years, is designed…

CSEM + LIMULA

Limula and CSEM partner to automate the production of CAR T cells

A Health Valley partnership to revolutionize cancer therapies and to bring a personalised treatment for cancer patients   CSEM supports…

Calciscon

€2M Eurostars funding for a project led by Calciscon

CALCISCON, AMSTERDAM UNIVERSITY MEDICAL CENTERS and ADMESY have signed a collaborative agreement for the development of a laboratory benchtop analyzer…

Xsensio

Xsensio announces an agreement with Mayo Clinic

Xsensio Announces Know-How and Stock Purchase Agreement with Mayo Clinic   Xsensio, a Vaud-Based company that is developing the Lab-on-Skin©…

CaverSTIM

Comphya raises CHF 850 000 in a convertible loan

Comphya SA, developer of the first neuromodulator to treat erectile dysfunction (ED), announced the fundraising of CHF 850k in a…

Pills ©maksim goncharenok

Research is less profitable for the pharmaceutical industry

According to a Deloitte study, investing in research is less and less interesting. The audit and consulting firm used figures…

Ibex™ Lonza facilit in Visp Switzerland

Lonza invested CHF 1 billion in Visp in 2022

The biopharmaceutical company employs 5,000 people in Valais, and also announced a 15% sales growth in 2022, representing a total…

Alithea Chuv Pamgene

CHUV, Alithea Genomics and PanGene partner to develop a pan-cancer blood test

The three partners secured a €1 million ($1.1 million) in Eurostars grant funding to develop a first of a king…

Magali Bischof Labiotech

BioAlps and the Swiss Health Valley

Listen to Magali Bischof, BioAlps Secretary General, on Beyond Biotech podcast speaking about the Swiss Health Valley and the role…

Chuv, Ludwig Institute, EPFL

CHUV, EPFL, SIB and Roche found molecules able to suppress resistance to immunotherapy

A breakthrough in the fight against cancer: researchers from EPFL, the Ludwig Institute of the CHUV, the SIB, and Roche…

HUG Center Virtual Medicine

The HUG open a Centre for Virtual Medicine

The new Centre for Virtual Medicine at the HUG is a pioneer in the use of virtual reality for clinical…

Bionomous

BIONOMOUS closes a USD 2.7 million Series A

The Swiss-based startup builds devices to automate processes in Life Science research and prepares a product rollout and expansion.  …

machineMD

Virtual reality glasses used as a diagnostic tool for brain disorders

MachineMD, a spin-off of Inselspital Bern, and CSEM, are collaborating to diagnose brain diseases by analyzing eye movements with a…

Neurosoft Bioelectronics

Neurosoft Bioelectronics receives ISO Certification for its Quality Management System

Neurosoft Bioelectronics SA, a startup developing implantable brain-computer interfaces, announces that it has received ISO 13485:2016 Certification by TÜV SÜD…

Bachem

A CHF 1 billion contract for Bachem Group

The contract covers the delivery of a large volume of peptides over a five-year period from 2025-2029, and follows the…

MPC Therapeutics

A CHF 1.5M seed-funding round for MPC Therapeutics to improve CAR-T cancer therapies

MPC Therapeutics (MPC Tx), is a Swiss biotechnology company based in Geneva, focusing on metabolism and cellular rejuvenation.   The…

ten23 health

Swissfillon becomes ten23 health

ten23 health®, a global contract development and manufacturing organization (CDMO) announces the change in branding of its in Visp, Switzerland…

Stalicla

STALICLA signs exclusive in-licensing agreement with Novartis for late-stage clinical neuropsychiatric and neurodevelopmental disorder treatment

The transaction with Novartis reinforces STALICLA’s position as the leading developer of precision medicines for neurodevelopmental disorders and heralds the…

mimiX biotherapeutics Ltd

mimiX biotherapeutics launches a funding round to accelerate clinical translation of FastSkin®

mimiX biotherapeutics launches a funding round to accelerate clinical translation of FastSkin® MIMIX BIOTHERAPEUTICS LTD, a Swiss medical technology company…

Resistell

Resistell AG closes its series B first tranche of CHF 8.5 Million

Resistell provides information on which antibiotic should be used to treat the patient, and the concentration at which it should…

iOnctura

iOnctura awarded EUR 17.5 million funding from the EIC Accelerator

Funding will support iOnctura’s clinical program for IOA-289, a first-in-class autotaxin inhibitor for the treatment of pancreatic cancer   iOnctura…

Biped

An intelligent harness to facilitate the mobility of blind people

The startup Biped created a harness equipped with 3D cameras that beeps when there is a risk of hitting an…

AMF Medical SA

AMF Medical SA bought for CHF 200 million by Tandem Diabetes Care

Tandem Diabetes Care, a global US-Based insulin delivery and diabetes technology company, announced an agreement to acquire AMF Medical SA,…

Pharma Suisse

Swiss research: the pharmaceutical industry is the leading investor in 2021

In 2021, private companies spent CHF 16.8 billion in Switzerland on in-house research and development (R&D) activities. This represents an…

The Scientist

Nanolive selected in the top 10 Innovations by The Scientist

The Scientist magazine announced its top 10 new products selected by a panel of independent judges. The Lausanne-based start-up Nanolive…

MRM Debiopharm Challenge

MRM wins the Debiopharm – La Solution – Inartis Challenge

The 7th Debiopharm-La-Solution.ch-Inartis Challenge for the Quality of Life of Patient has rewarded with a prize of CHF 25’000 the…

4à6 BioAlps

VR training for new Lonza employees

How to attract and retain talented workers in the Biotech Industry? And how to train the new recruits efficiently? Lonza…

Innosuisse 2023

Innosuisse, what changes in 2023?

As of January 2023, Innosuisse is evolving. Grants will be distributed for international projects, and the financing of start-ups will…

Alliance TT

Alliance, your partner for your Innosuisse application

You have an innovative project and are thinking of submitting an Innosuisse application? With its team of specialized advisors, Alliance…

Domo Health - Pépites

Domo Health: a digital platform for home health

Lack of resources and staff, aging population, an increase in chronic diseases: the challenges of the medical world are numerous…

Long Covid Syndrome

GeNeuro starts a clinical trials for its long COVID treatment

200 patients are recruited and will be followed in 5 Swiss hospitals participating in the study. The first results are…

Prof. Antoine Geissbuhler BioAlps President

Prof. Antoine Geissbuhler elected at the Royal Academy of Medicine of Belgium

A new mission for BioAlps’ President   Professor at the Department of Radiology and Medical Informatics of the Faculty of…

Symbios

Symbios opens a new factory in Yverdon

The 12 000 m2 facility will be ready next spring in the Y-Parc in Yverdon-les-Bains. Leader in the production of custom-made…

Volumina Medical

Volumina Medical Gets a CHF 500 000 Loan from FIT

Volumina Medical is an EPFL spin-off based in Biopôle Lausanne. The company develops a biogel that supports the repair of…

Switzerland sets to accept medical devices with FDA approval

The Federal Council is to adapt national laws so that, in addition to medical devices with an EU certificate /…

ONWARD

EUR 3.7 million for ONWARD and its partners from the European Innovation Council (EIC)

The European Innovation Council Grant has been awarded to ONWARD and its research partners, including EPFL, IICT-BAS, CEA-Leti-Clinatec, and CEAList….

Limula

Limula wins the start-up Swiss Technology Award

During the Swiss Innovation Forum on 23 November 2022 in Basel, Limula won the Inventor Award.   Two other companies…

Cern et CHUV

CERN, CHUV and THERYQ develop a revolutionary FLASH radiotherapy device to fight cancer

This FLASH radiotherapy device will use very high-energy electrons (VHEE) to treat cancers that are resistant to conventional treatments, with…

BioAlps Awards

Prof. Jocelyne Bloch and Prof. Grégoire Courtine receive the BioAlps Academia Award, and Incyte the BioAlps Industry Award.

The ceremony closed the BioAlps Networking Day on 24 November 2022 in Neuchâtel, in front of 250 key players of…

Dentsply Sirona

Dentsply Sirona wins the Vaud International Business Award

The dental products world leader employs 700 people in the canton.       Each fall, the Vaud International Business…

Obseva

ObsEva Announces Sale of Ebopiprant License Agreement to XOMA for up to $113 Million

The Swiss company expects the sale proceeds to resolve its current over-indebtedness position ObsEva SA, a biopharmaceutical company based in…

Opna bio

Opna Bio Raises $38M in Series A Financing

Opna Bio, an Epalinges, Switzerland and San Francisco, CA-based clinical-stage biopharmaceutical company, raised $38M in Series A funding. The round…

nicollier

Claude Nicollier steps down from his position as CSEM

The former astronaut has spent 16 years as Chairperson of the Board of Directors   Effective June 2023, Claude Nicollier…

Novigenix

Novigenix announces first closing of its $20M Series B

The company validated its approach in Colorectal Cancer (CRC) screening, and provides new molecular insights and predictive algorithms for patient…

Neuria

Neuria receives the Start-Up Innovation Prize of the Canton of Fribourg

Neuria gets CHF 30 000 to develop its digital therapy hidden in video games to help fight nutrition disorders  …

PeriVision

A CHF 1.6 million Innosuisse Grant for PeriVision

PeriVision was awarded an Innosuisse research grant together with the University Hospital Bern and ARTORG Center for Biomedical Engineering Research…

MICROCITY Neuchâtel, Land of Diagnostic

A Human lean Diagnostic programme in the canton of precision watchmaking   The historical heritage of high precision and core…

Domo Health Roche

Domo Health and Roche develop a digital health solution to detect the first signs of respiratory infections

Domo Health, a leader in digital health, announced the launch of its clinical study in collaboration with Roche Pharma Suisse…

Debiopharm Yona Link

Debiopharm leads $6M round for YonaLink to Scale Global Growth

The swiss company invests into an Israelian SaaS Platform able to collect data and to reduce clinical trial timelines and…

Neurorestore

Bone marrow neurons can be rewired to enable paraplegics to walk

Jocelyne Bloch and Grégoire Courtine, two Swiss researchers, have identified a group of nerve cells unrelated to the locomotor system…

Dr. Sacha Pierre Sidjanski

Interview Sacha Sidjanski

Dr. Sacha Pierre Sidjanski is in charge of External Relations at the Faculty of Life Sciences at EPFL. He explains…

BioAlps Incyte

🔺4à6 BioAlps at Incyte🔺

  On 22 September 2022, Jonathan Dickinson, executive vice-president at Incyte, received the Swiss Health Valley Community in Morges.  …

Novochizol Alpha Chitin

Novochizol SA and Alpha Chitin Partner to Produce a Chitosan-Based Polysaccharide

Alpha Chitin will manufacture both Novochizol™ raw materials and Novochizol™-based intermediate products.   Alpha Chitin, a French biobased chemistry company…

Sofia Genetics Microsft

SOPHiA GENETICS Partners with Microsoft to Accelerate Multimodal Health Data Analysis

The agreement is to expand and reinforce data-driven medicine through the SOPHiA DDM™ health data analysis platform available with Microsoft Azure…

CSEM Dixi Polytool

Dixi Polytool wins CSEM’s Digital Journey Contest

The company will receive CHF 100,000 in technical support from CSEM to develop a smart factory and a 100% autonomous…

Prof Kalia

Interview Prof. Yogeshvar Kalia

Prof. Yogeshvar Kalia is Professor at the Faculty of Pharmaceutical Sciences at the University of Geneva (UNIGE) speaks about the…

Microbiome

How does the microbiota work?

Researchers at the University of Bern and University Hospital Bern have been able to comprehensively study the bacteria of the…

HUG Endotelix

A new test to avoid miscarriages and strokes

The HUG and the Unige have found a way to better detect the antibodies that cause thrombosis, which leads to…

MedAlliance

Cordis spends 1.14 billion francs to buy MedAlliance

Nyon-based MedAlliance, a start-up active in the field of vascular medical technology, has been acquired by the American multinational Cordis…

NeSensing

Netsensing Technology finalists of the 14th Healthcare Innovation World Cup at Medica 2022

Incubated at Microcity Neuchâtel, Netsensing Technology is excited to announce that it has been selected as one of the Top12…

Denis Cavin

Interview Denis Cavin

Why is Western Switzerland is a perfect place for lifesciences companies? Listen to Denis Cavin, Economic Development Officer at State of Geneva…

Oculis

Oculis to go public

The Lausanne-based company Oculis SA, and European Biotech Acquisition Corp, announced a business combination agreement to create a Nasdaq-listed biopharmaceutical…

Sun Bioscience

SUN Bioscience receives an EPFL Alumni Awards

The two co-founders of SUN bioscience received an EPFL Alumni Award, a price that distinguishes researchers over the course of…

La Source research programme

Improving the working conditions of health care workers

Collecte d’informations pour un projet de recherche HEIG-VD / Institut et Haute Ecole de Santé La Source – Conciliation vie privée vie professionnelle – TOUTES LES SOLUTIONS DE TOUS LES SECTEURS D’ACTIVITE SONT LES BIENVENUES

Firmenich

Firmenich inaugurates its new campus in Geneva

The 225,000 m2 site, located in the towns of Satigny and La Plaine, has a largely automated production capacity of…

Orama VR

ORamaVR raises 2.4M EUR in a post-seed funding round

The leader in medical virtual reality (VR) training tools, based in Geneva, provides immersive virtual reality solutions that allow the…

HealthCare Konnect

BoneView®, an AI solution to improve fractures diagnostic on X-rays images

Gleamer and HealthCare Konnect (HCK) partner to expand access to AI-Based double check-in fractures, effusions, dislocations and bone lesions on…

Ron Appel Christophe Dessimoz

Ron Appel, SIB’s president, retires

Bioinformatics pioneer gives way to the next generation   Ron Appel pioneered the field of bioinformatics in Switzerland and supported…

ArcoScreen and DAAV

ArcoScreen and DAAV are FIT

ArcoScreen and DAAV both receive a Tech Seed loan of CHF 100’000 from the Foundation for Technological Innovation (FIT). ArcoScreen…

Endometriosis

Progress in the diagnosis of endometriosis

Researchers from the University of Bern and Inselspital and University Hospital Bern, in collaboration with Australian scientists, are developing a…

Flowbone team

Flowbone SA concludes a CHF 2.1 million Seed round

The EPFL spin-off, active in the field of bone regeneration, prepares its US market entry.   “With aging population, fractures…

Unige Hepatite B

A UNIGE team reveals how Hepatitis B could be cured

The swiss🇨🇭 researchers have deciphered the precise functioning of a protective mechanism that could lead to a potential post-infection treatment…

Top 18 European Biotech startups

Four Swiss🇨🇭 start-ups in the Top 18 European TechBio companies

ONWARD, Haya Therapeutics, Retinai and Engimmune Therapeutics are in the top 18 Biotech companies in Europe according to investors. Stuck…

Volumina Medical

Volumina Medical closes its Series A funding to develop Adipearl

Clinique La Prairie and Skyviews Life Science Ltd are among the new investors   Volumina Medical, a spin-off from the…

Biopôle SA

Three new buildings on the Biopôle site in Lausanne

Biopôle SA announces a new partnership with Edmond de Rothschild Real Estate SICAV for the construction of three new buildings…

Fongit Fund

iOnctura, EBAMed and Terapet awarded by the Fongit

Fongit, the Fondation Genevoise pour l’Innovation Technologique, has just announced the latest beneficiaries of the Fongit Innovation Fund (FIF). iOnctura…

Future of Health Grant

Future of Health: 10 digital healthcare start-ups awarded

EPFL Innovation Park and CSS present the 2022 cohort   The Future of Health Grant programme to support innovation in…

Nanolive

Nanolive SA closes a series C round at $22.2 million

After the successful closing of a US $22.2 million Series C equity financing, Nanolive announces the appointment of two extraordinary…

Hedera Dx

Hedera Dx raises €14 million in seed funding

The Swiss companies wants to accelerate the adoption of liquid biopsies for cancer testing   Swiss techbio company Hedera Dx,…

Incepto

Incepto raised €27 million

The platform for artificial intelligence solutions applied to medical imaging, announces a €27 million round of financing. The goal: to…

Onward Arm Injury

Onward Confirms Amazing Results to restore Arm and Hand Function in People With Spinal Cord Injury

The Up-LIFT study evaluating ARC-EX Therapy demonstrated the effectiveness of the device to improve extremity strength and function in people…

A year of Swiss biological and biomedical data science: SIB Swiss Institute of Bioinformatics

Discover some of the key highlights of the national organization for biological and biomedical data science in the SIB Profile 2022, our annual activity report. Together, our infrastructure solutions, expertise and interdisciplinary collaborations foster better science and healthcare, and give Switzerland a strong voice in global issues around life science data.

Selexis - Next Immune

Selexis and NexImmune Sign an Agreement to Advance Multiple Immunotherapies Targeting Rare Cancers

This Agreement supports the development of molecules targeting acute myeloid leukemia, multiple myeloma, human papillomavirus (HPV) associated tumors, and additional…

Debiopharm Whitelab Genomics

Debiopharm Innovation Funds invests to accelerate the development of genomics medicines via technology powered AI

The strategic investment arm of Swiss biopharmaceutical company Debiopharm wants to reduce biotherapies’ development time and cost using AI (Artificial…

Top 100 startups

Top 100 Swiss Startups 2022: the Life Sciences Winners

17 Western Switzerland Life Sciences startups in biotech, medtech and foodtech were selected   The TOP 100 Swiss Startup Award 2022…

Novartis 100 million investment

Novartis invests CHF 100 million in Basel

A new state-of-the-art biologics centre   Novartis announced plans to invest around CHF 100 million in the development of next-generation…

BCC Fribourg

New Gene Therapy Laboratory at the Biofactory Competence Center (BCC) in Fribourg

A jewel for biopharmaceutical education and research   The Biofactory Competence Center (BCC) in Freiburg inaugurated its new gene therapy…

Forum des 100

Forum des 100 – Le Temps

Two BioAlps experts nominated   Two Life Sciences experts, Dominique Truchot-Cardot and Alexandre Pauchard, are among the 100 personalities of…

machineMD

machineMD raises CHF 3.2 Million

T‍he MedTech startup is developing a medical device for the early diagnosis of neurological disorders including brain tumors via neuro-ophthalmic…

Chuv Trisomie 21

CHUV, HUG and Inserm help Down syndrome patients to get better

The injection of the hormone GnRH improved the cognitive functions of several Down syndrome patients   An Inserm team within…

AC Immune MJFOX

Parkinson’s Disease: AC Immune Receives a Grant from The Michael J. Fox Foundation

A new USD 0.5 million grant brings up to USD 3.7 million the total amount The Michael J. Fox Foundation…

Sensawear

A wearable tissue health monitor

Sensawear wins a CHF 150,000 Venture Kick grant to develop its wearable tissue health monitor   Sensawear has developed the…

SightIn Health

SightIn Health wins a CHF 150,000 Venture Kick grant

The Swiss start-up wants to develop an AI-SaaS to democratize the use and interpretation of ultrasound   SightIn Health’s Machine…

Day One Jura

DayOne Tech Accelerator presents its first cohort

The DayOne Tech Accelerator in the Canton of Jura has just announced its winners. Three Medtech startups are starting a…

AC Bioscience

AC BioScience closes a 4th seed-round of CHF 2.5 million

AC BioScience, a Biopôle-based clinical-stage biotech company pioneering the development of novel therapies in immuno-oncology and tumour vascular normalization, announces…

Alcon

Alcon buys Aerial Pharmaceutics for $770 million

Ophthalmic devices and Geneva-based Alcon has reached an agreement to acquire North Carolina-based Aerie Pharmaceuticals for $770 million (743.1 million…

Sandoz and Novartis

Novartis to list its subsidiary Sandoz on the stock exchange

Under consideration since 2021, the details of the demerger of Sandoz, the generic drug arm of Swiss pharmaceutical giant Novartis,…

Twiice

Twiice’s exoskeleton allows paralysed people to walk again

Vaud-based and EPFL spin-off startup TWIICE receives a CHF 100 000 seed loan from FIT   Every year, around 250,000…

Abionic

Abionic’s test diagnoses sepsis 3 days before the standards methods

Abionic’s test identifies in 5 minutes the earliest signs of sepsis 3 days before the standard of care. The technology…

Obseva

ObsEva plans job cuts

The ObsEva laboratory is to engage in a vast restructuring process in the face of difficulties encountered with the FDA…

Dexter Distalmotion

Dexter®, the Swiss surgery robot, makes its way to Germany

The Dexter® on-demand robotic surgery system created by the swiss company Distalmotion is now used by the Department for Women’s…

Debiopharm Unige

Debiopharm signs an new IDEAL agreement with the University of Geneva

Debiopharms and UNIGE want to fight together against cancer and drug-resistant bacterial infections JULY 25, 2022   Debiopharm, a Swiss…

Nano Decoder

Using proteins as barcodes to fight against counterfeiting

Nanodecoder, an EPFL spin-off, receives CHF 100 000 from FIT   The Fondation pour l’Innovation Technologique selection committee announced they…

Nestlé - Enterome

Nestlé Health Science invests EUR 40 million in Enterome

Nestlé Health Science has signed a collaboration agreement with French company Enterome to target food allergies and chronic intestinal diseases…

Nestlé & Perseo Pharma

Nestlé Health Science and Perseo Pharma partners to fight digestive diseases

Strategic collaboration to create therapies against digestive diseases   Perseo pharma, a preclinical stage biopharmaceutical company focused on breaking new…

ADC Therapeutics

ADC Therapeutics signs multi-million dollar licensing agreement with Sobi

The swiss and the Swedish companies partner for the development and commercialization of ZYNLONTA®, a drug for hematologic and solid…

Gnubiotics

Gnubiotics gets a CHF 1.4 million Innosuisse Grant

The biotech company evaluates the effects of glycopeptides on solid tumors   Gnubiotics Sciences, a biotech company pioneering the discovery…

b-ray Z

CHF 4 million for b-rayZ AG, a startup fighting breast cancer

The Tech4Eva alumni and University Hospital Zurich (USZ) uses AI for faster and better breast cancer diagnostics     b-RayZ AG…

Selexis - kbi

KBI Biopharma SA and Selexis SA inaugurated a new facility in Geneva

KBI Biopharma SA (KBI) and Selexis SA, both JSR Life Sciences companies, have inaugurated an expanded, fully-integrated mammalian contract development…

The State of Vaud commits on giving CHF 2 million / year to the Fondation pour l'Innovation Technologique (FIT)

The canton of Vaud keeps on backing the FIT

The State of Vaud commits on giving CHF 2 million / year to the Fondation pour l’Innovation Technologique (FIT)  …

Lonza, stein

Lonza opens a new production facility in Stein (CH)

Lonza plans to construct a large-scale commercial drug product fill and finish facility in Stein (CH). CHF 500 million will…

Vaud Investments Life Sciences

Vaud invests CHF 178 Million in Life Sciences

To strengthen the development of the Canton and in particular the expertise of the CHUV and the University of Lausanne…

CSEM and Clexbio Team

Supervene: growing humain vein tissues

ClexBio, a Norway-based startup, is teaming up with CSEM to develop the world’s first machine to grow tissue-engineered human veins…

Magali Bischof, Secretary General of BioAlps (L) with George Kouvas Chief Technology Officer at the Wyss Center (R)

Wyss Center joins life sciences cluster BioAlps 

The Wyss Center for Bio and Neuroengineering, a non-profit organization dedicated to accelerating discoveries in neuroscience to improve patient lives,…

Madiha Derouazi (right) and Elodie Belnoue (left)

Geneva researcher wins European Inventor’s Award

Geneva-based researcher Madiha Derouazi is co-winner of the European Inventor Award. With the French immunologist Elodie Belnoue, she is rewarded…

ten23health

ten23health is building a new facility in Visp

The company plans to establish a new 5,000 m2 manufacturing facility in Visp.    In October 2021, ten23 health acquired a…

Ecotope 1

Ecotope, the new EPFL Innovation Park’s project

EPFL Innovation Park is turning 30 this year and wants to expand. A new site, called Ecotope,  will bring together…

ORama VR

A CHF 12 Million Innosuisse Grant for a VR Surgical Training Method

The Swiss Federal Agency for Innovation Promotion (Innosuisse) is supporting the “PROFICIENCY” project, in which the Geneva-based startup ORamaVR S.A….

Limula wins a prestigious EIC grant of €4.7 million

By combining its novel bioreactor with state-of-the-art sensors and predictive data intelligence, Limula will add significant value to its cell & gene therapy manufacturing solution, paving the way for in-process control for the production of highly personalised cancer treatments.

AlveoliX Swiss Medtech Award

AlveoliX wins the Swiss Medtech Award 2022

Bernese start-up AlveoliX was awarded the Swiss Medtech Award, and prize money totaling CHF 75,000.   AlveoliX, founded in 2019,…

Solange Peters Chuv

CHUV strengthens its strategy to fight cancer

The University Hospital of Vaud (CHUV) in Lausanne is expanding its strategy to better fight all forms of cancer. The…

BioAlps OM Pharma 4à6

BioAlps at OM Pharma

On 9 June 2022, during a BioAlps’ 4à6 event, the Heath Valley Community had the opportunity to visit OM Pharma…

Cityva 3D

Cytiva opens a new production site in Grens (VD)

Cytiva opens its new 7,400 m2 production facility in Grens, Switzerland, on 31 May 2022.   The site will manufacture…

Top Swiss Startups

Votes are open for the TOP 100 Swiss Startups! 

What is your favorite swiss startup?   Every year the TOP 100 Swiss Startup Award showcases the 100 most innovative…

Prof. Antoine Geissbuhler BioAlps President

Pr. Antoine Geissbuhler is the new BioAlps’ President

A Digital Health specialist to promote the Swiss Health Valley and the number one and most diversified Life Sciences Cluster…

Alithea Genomics

Alithea Genomics closes a CHF 1 million seed round

Alithea Genomics, a Lausanne-based fast-growing, emerging leader in the field of RNA sequencing and transcriptomics analysis, announced the closing of…

Dr. Andrea Pfeifer Ac Immune SA

Dr. Andrea Pfeifer received the Aenne Burda Award

The CEO and Director of AC Immune SA was recognized for her work to find treatments for Alzheimer’s disease  …

Kodiak Sciences and Lonza open a new facility in Visp

Kodiak Sciences and Lonza open a new facility in Visp

Kodiak Sciences Inc. (Nasdaq: KOD), a biopharmaceutical company committed to researching, developing and commercializing transformative therapeutics to treat retinal diseases,…

Spark centre for movement science and technologies

SpArk, the centre for movement science and technologies, is born!

This new centre, dedicated to sport and performance, is the result of collaboration between the City of Sion and The…

Hansjorg Wyss

Hansjörg Wyss, the life sciences philanthropist

On 17 May 2022, Hansjörg Wyss received the Gallatin Award from the Swiss American Chamber of Commerce for his great…

Onward 1

ONWARD’s Neurostimulator Restores Mobility for Patients with Spinal Cord Injury

This is the first time the ARCIM is used on a human patient. This implantable pulse generator (IPG) stimulates the…

HemostOD

HemostOD creates ex vivo blood platelets

HemostOD has developed a solution for ex vivo on-demand production of blood platelets. The company just received a CHF 100…

Biotech

Swiss biotech companies attracted investments of $3.33 billion in 2021

Last year was ‘the second best year in terms of fundraising’, according to the Swiss Biotech Association. The sector benefited…

Claude Clément

Podcast: Claude Clément

BioAlps President, Claude Clément, discusses career choices and how to lead innovation in the healthcare industry in the podcast What To Do…

Debiotech

A revolutionary home dialysis device made in Switzerland

The VersiTMPD Cycler System conceived and developed by Debiotech and licensed to Fresenius Medical Care receives FDA clearance

Merck Serono Christophe Martin

Merck Serono improves quality control with IA

Artificial Intelligence helps to assess the severity of a manufacturing incident in a medicine production unit   In any factory,…

Limula Ceidos Stemmatters

EUR 1 million Eurostars grant for Limula and Ceidos

The two swiss biotech startups signed an agreement with Stemmatters in Portugal. They received a Eurostars grant of EUR 1.14…

startup invest

Switzerland is high on the financing of medical startups

Switzerland ranks fourth in Europe in terms of the number of deals behind Britain, Germany and France.   Last year,…

Plair SA raised CHF 2,7 million

A grant to fund the Rapid-C Real-Time Microbial Detector    Plair SA, based in Plan-les-Ouates, Geneva, has been awarded CHF…

Artiria Medical

Artiria Medical raised CHF 3.8 million to improve stroke treatment

Artiria Medical, a swiss neurovascular start-up, raised CHF 3.8 M, including a CHF 2.7 M grant from the highly selective…

Neuro Restore

An electronic implant helps a bedridden patient to walk again

Researchers at the NeuroRestore research center in Lausanne Switzerland helped a patient suffering from a neurogenerative disease to leave her…

Neurosoft Bioelectronics

Neurosoft Bioelectronics raised CHF 3 Million

The Geneva-based company developed soft and flexible electrodes which can seamlessly interface with the brain   Neurosoft Bioelectronics, an early-stage…

Western Switzerland, paradise for Life Sciences Companies

18 new foreign life sciences companies settled in our region in 2021   Last year, according to GGBa’s annual report,…

Tech4Eva

Tech4Eva 2022 cohort

13 growth-stage startups and 15 early-stage start-ups and projects have been selected for the 2022 program.   Tech4Eva is an…

Nanolive raises US $ 20 million

The Swiss company is a pioneer in the development of live-cell imaging, and digital analytical solutions The swiss leading live-cell…

Venturelab Medtech Team 2022

Venture Leaders Medtech Team 2022

Ten startups have been chosen by a jury of investors as the Swiss National Startup Team for Venture Leaders Medtech…

MEC at Campus Biotech

A MEG plateform at Campus Biotech in 2022

A new device for brain research at the Campus Biotech   Next summer, the Human Neuroscience Platform (HNP) at Campus…

Wyss Center

Completely locked-in man uses brain-computer interface to communicate

Researchers at the Wyss Center Geneva created a device and a computer program to decode brain signals   Completely paralyzed…

Ana Pinto

INTERVIEW – Ana Pinto

🔺 Why Western Switzerland🇨🇭 is so attractive to life sciences companies? Ana Pinto, Business Partner at the Service de l’Économie…

Parithera Device

Parithera raises CHF 100 000 from FIT

The Foundation for Technological Innovation (FIT) has granted a CHF 100’000 Tech Seed loan to Parithera and its ExTrace Dx…

Nagi Bioscience

Nagi Bioscience won a € 2,5 million grant from the EIC Accelerator

The company revolutionizes pre-clinical testing with its pioneer Organism-on-Chip technology   Nagi Bioscience has been bestowed the prestigious and highly…

Swiss Medtech Ukraine

Medical devices for Ukraine

The Ukraine Embassy launches an appeal for donations   Collection points in Switzerland The war in Ukraine has thrown millions…

SEED Biosciences raises CHF 400 000

The EPFL spin-off has developed a pipetting robot that can dispense individual cells one by one.   The device, called…

Parkinson Disease

A gene could prevent Parkinson’s disease

A mutation in the Fer2 gene causes motor deficiencies in flies   The laboratory of Emi Nagoshi, Professor in the…

Monthey BioArk

BioArk Monthey is expanding

A third building is under construction at BioArk Monthey Until now, BioArk has offered 6,000m2 of space between its first…

Ceidos Founders

Ceidos revolutionises cell culture

The BioArk startup received a CHF 100 000 loan from FIT Advanced therapy medicinal products (ATMPs) are active medicines that…

Superlab Lausanne

Superlab Suisse Lausanne

A coworking space designed for scientists   Located in the Biopôle in Lausanne, Superlab Suisse offers ready to move in…

Unige breast Cancer

UNIGE: Fighting breast cancer cells growth

A low rate of a specific protein triggers tumors development. A UNIGE team found the counter-attack   In about 2/3…

Li Tang CEO Leman Biotech EPFL

$11 million for EPFL spin-off Leman Biotech

A protein that boosts the immune system can cure 90% of cancer in mice   Immunotherapy, which aims to boost…

GSK Haleon

GSK’s new company Haleon will have a site in Nyon

The pharmaceutical group GlaxoSmithKline creates Haleon, a new company from the separation of its consumer healthcare business. This entity will…

Neo Medical

Neo Medical raises $20 million for its AR technology for spine surgery

Swisscom Ventures is the lead investor in this round. The Vaud-based company will use the new funds to accelerate the…

Massimo Nobile

INTERVIEW : Massimo Nobile

🔺 Massimo Nobile, SwissBiotech Center CEO, explains how digital and life sciences are converging to create new medicines and treatments.

MindMaze

MindMaze secures a $105 million financing round

After a banner-year, the Lausanne-based company MindMaze secures $105 Million Financing, led by Concord Health Partners, and initiates American Hospital…

Leucine Project

Leucine project: a new hub for life sciences in Lausanne

New working spaces at Biopôle Campus Lausanne Biopôle SA, in collaboration with CPEV, is developing the Leucine Building, a new…

Carrol-Plummer-and-Nigel-Wallbridge

PhytlSigns raises CHF 500 000 for a plant monitoring system

The ‘Fitbit of Plants’ uses AI sensors to monitor crops   The startup Vivent provides growers with a technology to…

Miniature Raphaël Conz

INTERVIEW : Raphaël Conz, BioAlps vice-president

🔺 Raphaël Conz, Head of the Business Unit at the Department for the Promotion of the Economy and Innovation of…

Animal Testing

Swiss voters reject ban on animal testing

Voters have rejected a complete ban on experiments on living creatures in Switzerland.   The idea of putting an end…

Adaptyv Biosystems

Adaptyv Biosystems raised CHF 2.5 million in a pre-seed funding

Adaptyv Biosystems is to create the world’s largest protein design database   The company, based in Biopôle in Epalinges, is…

Genolier Innovation Hub

Genolier Innovation Hub

A new medical Innovation Hub will open in 2024   “This is not a real estate project to house the…

Haya Therapeutics

Haya Therapeuthics closes US$ 5 Million seed extension

The Lausanne-based company will open a branch office in San Diego to continue its growth   HAYA closes US$ 5…

Miniature Claude Clément

INTERVIEW : Claude Clément, BioAlps President

  🔺 Claude Clément is BioAlps President. According to him, multiculturality is why Switzerland🇨🇭 has become so successful in the…

Science first, politics second

The “Stick to Science” petition aims to allow Swiss and British researchers to remain in Horizon Europe programme.   The…

.NeuroRestore

An implant could cure paralysis

A new implant enables patients with a complete spinal cord injury to stand, walk and even swim    Michel Roccati,…

La Source

La Source Launches H4

La Source opens an innovation platform dedicated to care and health in Vaud (Switzerland).   The H4 “Hands-on Human Health…

Distalmotion

Distalmotion | $ 90M to make sense of robotic surgery

A partnership of medtech pioneers and company-builders   Distalmotion, based in Lausanne (Switzerland), Revival Healthcare Capital and 415 CAPITAL announced…

Takeda

Takeda | New building in Neuchâtel estimated at CHF 30 million

The pharmaceutical group Takeda wishes to increase the production capacity of its site in Neuchâtel (Switzerland) and will build a…

ADC Therapeutics

ADC Therapeutics | $30 million in new partnership deal

Development & commercialisation of ZYNLONTA in Japan   ADC Therapeutics SA, a commercial-stage biotechnology company improving the lives of those…

Swiss Institute of Bioinformatics (SIB)

SIB | Discover the newest resources in SIB’s infrastructure portfolio for the Life Sciences

Development of national secure platforms, leading open science databases & software tools    The Swiss Institute of Bioinformatics (SIB)’s mission,…

Antio Biosciences

Antion Biosciences | Exclusive collaboration & global license agreement with Allogene Therapeutics

Multiplex miCAR™ Technology   Allogene Therapeutics, a clinical-stage biotechnology company pioneering the development of allogeneic CAR T (AlloCAR T™) products…

Adiposs SA

Adiposs | Raised CHF 1.8M 1st closing of its Pre-Series A round

CHF 1.8M to start clinical trials & product industrialisation   Adiposs SA, the developer of a unique diagnostic product for…

Venture Kick

Record-high startup support for Swiss university spin-offs in 2022

89 new innovative projects in 2022   Venture Kick continues its success story and increases its budget: having supported 841…

Magali Bischof

Magali Bischof to become the new General Secretary of BioAlps

Magali Bischof promoted Secretary General of the BioAlps Association   The Executive Committee of the BioAlps Association has chosen Mrs…

GeNeuro

GeNeuro | CHF 6.7 million for the development of COVID-19 medicines

GeNeuro received CHF 6.7 million in funding for the development of temelimab against Long-COVID   GeNeuro, a biopharmaceutical company developing…

Merck & Chord Therapeutics

Merck acquires Geneva-based biopharmaceutical company Chord Therapeutics

Merck invests into Cadribine to try to cure rare neuroinflammatory diseases   Chord Therapeutics (Chord), a clinical-stage biopharmaceutical company developing…

Xsensio

Xsensio | CHF 4.2 million to accelerate market launch

1st closing new financing round with Swiss & international investors   Xsensio, a Lausanne based startup seeking to address the…

D36.ch

Intellias and D36.ch join forces

In November 2021, Intellias, a technology partner of Fortune 500 companies and top-tier organizations, and D36.ch, an innovative Swiss healthcare startup, announced their strategic partnership. The companies are joining efforts to build a bridge between the Swiss digital health market and world-class IT services to reinforce customers’ digital strength by combining 360-degree domain expertise with state-of-the-art software engineering solutions.

Biopôle SA

Biopôle | Partnership programme with Swiss Medical Network

Biopôle SA’s innovative life sciences community continues to grow with the addition of Swiss Medical Network, one of Switzerland’s leading private…

Sun genomics

Sun Genomics | Sets up European subsidiary in Fribourg (Switzerland)

1st establishment of a US company in Western Switzerland without prior in-person meeting   A first for the canton of…

Heidi.news | BioAlps: 20 years of innovation

Medical innovation & contribution to the future of medicine   On 30 November, 2021, Mrs Annick Chevillot (Heidi.news) has moderated…

HEIG-VD

Appointment of a new Full Professor at HEIG-VD

Underlines the ambition of the HEIG-VD to pursue its development in management applied to the health sector, both in the field of education and research

HealthCare Konnect

Deep Bio and HealthCare Konnect | Improving cancer diagnosis

Deep Bio and HealthCare Konnect (HCK) partner to improve cancer diagnosis in Switzerland and North Africa   On 18 October…

OM Pharma

BioAlps | 20 years of innovation | OM Pharma

Investing, innovating and hiring in Switzerland to prevent infection worldwide   We are pleased to share with you our new…

Debiopharm

BioAlps | 20 years of innovation | Debiopharm

Debiopharm | We develop for patients   We are pleased to share with you our new testimonial series as part…

Ichnos

BioAlps | 20 years of innovation | Ichnos

Developing first-in-class bi-/trispecific antibodies to treat cancer patients   We are pleased to share with you our new testimonial series…

Swiss Pathogen Surveillance Platform

Creation of the Swiss Pathogen Surveillance Platform SPSP

Switzerland establishes a national infrastructure to track COVID-19 and its variants Discover the role of the Swiss Pathogen Surveillance Platform…

Pharmalp

BioAlps | 20 years of innovation | Pharmalp

Developing and distributing efficacious natural healthcare products   We are pleased to share with you our new testimonial series as…

CSL

BioAlps | 20 years of innovation | CSL Behring

Fast-tracking innovation through long-term mutual partnerships with academia   We are pleased to share with you our new testimonial series…

Vifor Pharma

BioAlps | 20 years of innovation | Vifor Pharma

On a mission to help patients live better, healthier lives   We are pleased to share with you our new…

BioArk

BioAlps | 20 years of innovation | BioArk

Strengthening the Life Sciences value chain from discovery to market   We are pleased to share with you our new…

HES-SO

BioAlps | 20 years of innovation | HES-SO

Supporting the Swiss economy with locally rooted training and applied research   We are pleased to share with you our…

Selexis

BioAlps | 20 years of innovation | Selexis

Selexis | Cell line development meets lab automation and robotics for biologic therapeutic manufacturing   We are pleased to share…

Fongit

BioAlps | 20 years of innovation | Fongit

Fongit | Switzerland’s premier startup incubator   We are pleased to share with you our new testimonial series as part…

SILAB

BioAlps | 20 years of innovation | SILAB

SILAB ǀ Dedicated to promoting a relevant and sustainable innovation in healthcare   We are pleased to share with you…

UNIL

BioAlps | 20 years of innovation | UNIL

UNIL | A commitment to transforming Life Sciences into concrete actions for the benefit of all   We are pleased…

CERN

BioAlps | 20 years of innovation | CERN

CERN | Unique technologies with a wide scope of applications   We are pleased to share with you our new…

Netsensing

BioAlps | 20 years of innovation | Netsensing

Netsensing | Saving lives through the detection of sleep apnea   We are pleased to share with you our new…

JAG

BioAlps | 20 years of innovation | JAG

JAG | Highly automated process plants for the pharmaceutical and biotech industries   We are pleased to share with you…

GGBa

BioAlps | 20 years of innovation | Greater Geneva Bern area

GGBa | The official investment promotion agency for Western Switzerland   We are pleased to share with you our new…

Gnubiotics

BioAlps | 20 years of innovation | Gnubiotics

Gnubiotics | Novel microbiome health solutions   We are pleased to share with you our new testimonial series as part…

GeNeuro

BioAlps | 20 years of innovation | GeNeuro

Fighting against neurodegenerative and autoimmune disease with antibodies   We are pleased to share with you our new testimonial series…

Neurix

BioAlps | 20 years of innovation | Neurix

Minibrain technology enabling efficient drug testing and development   We are pleased to share with you our new testimonial series…

Coat-X

BioAlps | 20 years of innovation | Coat-X

Thin-film encapsulation technology helping increase product reliability and miniaturisation effectiveness   We are pleased to share with you our new…

UCB

BioAlps | 20 years of innovation | UCB

UCB | Creating value for patients now and into the future   We are pleased to share with you our…

EPFL

EPFL | Research with animals

A necessity for scientific progress   Despite the many advancements in developing innovative alternative methods, animal testing still plays an…

Swiss Biotech Association

BioAlps | 20 years of innovation | Swiss Biotech Association

SBA | Representing the interests of the Swiss biotech industry   We are pleased to share with you our new…

Socorex

BioAlps | 20 years of innovation | Socorex

60 years of high-quality manufacturing of liquid handling instruments   We are pleased to share with you our new testimonial…

Debiotech

BioAlps | 20 years of innovation | Debiotech

Key medtech player fostering innovative medical software solutions and device development projects   We are pleased to share with you…

Biopôle

BioAlps | 20 years of innovation | Biopôle

High-quality support and valuable community for life sciences companies   We are pleased to share with you our new testimonial…

KATZAROV

BioAlps | 20 years of innovation | KATZAROV

Intellectual property for Life Sciences innovators   We are pleased to share with you our new testimonial series as part…

Incyte Bioplant

New Incyte bioplant opens in Switzerland

Incyte opens its new bioplant in Yverdon-les-bains in the Canton of Vaud   On 31 August 2021, Incyte, the US-based…

CSEM

BioAlps | 20 years of innovation | CSEM

Supporting the Life Sciences industry with cell-tech, biomonitoring and lab automation know-how   We are pleased to share with you…

iOnctura

BioAlps | 20 years of innovation | iOnctura

iOnctura | Better drugs to beat cancer resistance   We are pleased to share with you our new testimonial series…

Combioxin SA

Combioxin signs a worldwide licensing agreement

Combioxin has signed a worldwide licensing agreement with Eagle Pharmaceuticals Eagle Pharmaceuticals has entered into a worldwide licensing agreement with…

AC Immune

BioAlps | 20 years of innovation | AC Immune

Addressing the slow pandemic of neurodegenerative diseases   We are pleased to share with you our new testimonial series as…

Innovaud

BioAlps | 20 years of innovation | Innovaud

Connecting tech-oriented companies | Supporting cross-cutting innovation   We are pleased to share with you our new testimonial series as…

Geneus

BioAlps | 20 years of innovation | Geneus

Life Sciences innovation initiator | Transforming ideas & research into startups   We are pleased to share with you our…

SIB Swiss Institute of Bioinformatics

BioAlps | 20 years of innovation | SIB Swiss Institute of Bioinformatics

SIB | Supporting the Life Sciences community with Computational Biology and Bioinformatics know-how   We are pleased to share with…

Abionic

BioAlps | 20 years of innovation | Abionic

Nanotechnology to detect sepsis in 5 minutes from one drop of blood   We are pleased to share with you…

HEPIA Tissue Engineering Lab

BioAlps | 20 years of innovation | HEPIA Tissue Engineering Lab

Microtech tools meet novel integrated in vitro cellular model to help accelerate research    We are pleased to share with…

Lunaphore

Lunaphore | Top 10 Spatial Biology Companies

Lunaphore was selected as one of the top 10 spatial biology companies in the world   Lunaphore Technologies has been…

Fongit

FONGIT Innovation Fund selects four startups

FIF | FONGIT Innovation Fund Following the announcement of the creation of the FONGIT Innovation Fund (FIF), the foundation supporting…

Distalmotion

Distalmotion | Pioneering Hybrid Robotics in General Surgery

CHUV performed the world’s first hybrid robotic general surgery   Distalmotion & CHUV announced the successful start to a case series…

EBAMed

EBAMed | Prospective Imaging Study

First patient enrollment   EBAMed announced first patient enrolled in prospective imaging study with ultrasound guidance prototype in ventricular tachycardia…

SOPHiA GENETICS | Opts for Nasdaq IPO

Closing of $234 mio. Initial Public Offering & $20 mio. Private Placement   SOPHiA GENETICS SA (Nasdaq: SOPH), the creator…

Oncology

CHUV | A breakthrough in oncology

CHUV | Biomarkers which could save lives   Scientists at CHUV have identified cells which create metastasis in a tumour….

Merck

Merck | New Biotech Development Center

Merck reaches key milestone in the construction of its Biotech Development Center Announced in January 2020, Merck‘s new state-of-the-art biotech development…

Asceneuron

Asceneuron | Appoints new Board Member

Underscores company’s ambition to deliver on the unmet needs of patients living with neurodegenerative diseases

Drug Discovery World

Drug Discovery World | Switzerland as a global biotech hub

Why Switzerland continues to punch above its weight as global biotech hub | Drug Discovery World To understand Switzerland’s continued…

AC Biosciences

AC BioScience | Committed to fight against cancer

Interview with Andreas Schläpfer, CEO & cofounder   AC BioScience, the Vaud based company is a pioneer in the development…

EPFL

EPFL | A virus to identify small peptide mimics of antifreeze proteins

Scientists at EPFL (Polymers Laboratory) and the University of Warwick have used a virus to identify a peptide that can…

EPFL

EPFL | Next-generation implants will be biodegradable and non-invasive

Tissue grows back once the implant is gone   EPFL engineers have developed a neural interface that disappears harmlessly in…

CSEM

CSEM | Solid 2020 results despite the tough economic climate

Digital support to Gait Up    CSEM posted a solid financial performance in 2020 and made further progress on important technological…

Swiss Diabetes Venture Fund

Swiss Diabetes Venture Fund | 1st venture fund dedicated to diabetes technology

CHF 50 million for diabetes ventures Launch of the first venture fund dedicated to diabetes technology, through a collaboration between…

UNIGE

UNIGE | How do immune cells get activated?

Decoding the activation mechanism of the CCR5 receptor By studying the structure of cellular receptors and of the molecules that…

EPFL

EPFL | Tailored optical stimulation for the blind

Stimulation of the nervous system with neurotechnology EPFL scientists in a European collaboration propose a personalised protocol for optimising stimulation…

CERN

CERN | CLEAR study paves the way for novel electron-based cancer therapy

High-energy electron beams can be focused onto deep-seated cancerous tumours   The study, conducted at CERN’s CLEAR test facility, demonstrates…

PharmaPlan

Pharmaplan (TTP Group) | New office in Visp close to Lonza

New office with 60 employees   In response to the investment boom in the pharmaceutical industry, Pharmaplan is opening another…

LABIOTECH.EU

Top 15 Swiss biotech startups making a difference in Europe

This article was written by Labiotech.eu with the support of BioAlps, the Greater Zurich Area, and Switzerland Global Enterprise (S-GE)….

Fondation Leenaards

Leenaards Foundation | Science Prize 2021

CHF 1.4 mio for biomedical research in the Lake Geneva region   The Leenaards Foundation has awarded Science Prizes to…

HEIG VD

HEIG VD | Rethinking the manufacture of cell & gene therapies

  HEIG-VD is joining forces with the EPFL and the University of Geneva (UNIGE) to take up the challenge of…

Embion

Embion | Nominated for the Swiss Economic Award 2021

The most important prize for young entrepreneurs in Switzerland   From dozens of applications, nine companies were nominated for the…

EPFL

EPFL | How healthy is your digital twin?

Ethical & legal questions   Digital twins – a savvy combination of artificial intelligence and personal data – have already…

Venturelab

Venturelab | Venture Leaders Medtech 2021

Meet the Swiss national MedTech team   The Swiss National Startup Team has 10 new members: 10 startups were selected…

Abologix

Abologix | Wins CHF 150,000

Sum used to develop targeted antibodies for cancer patients   Abologix develops a new therapeutic option to treat lymphoma patients…

Rheon Medical

Rheon Medical | 1st implantation of the “Eyewatch” implant in Valais

The eyeWatch system is the world’s first adjustable system for treating glaucoma   The first patient in Valais has benefited…

UNIGE

UNIGE | Replicating patients’ tumours to test different treatments

The critical role of the immune system in the fight against cancer   UNIGE Researchers have developed in vitro tumour…

GGBa

GGBa | Geneva welcomes new global health investment advisory

Geneva as a center for global public health development   Initially launched in the United States, Baraka relocated to Geneva…

EarlySight

EarlySight | Seed round closing

1st closing round of CHF 2.3 million   EarlySight is delighted to announce the first closing of CHF 2.3 million…

Selexis

Selexis | “Best Workplaces™ Switzerland” 2021

One of the Best Workplaces™ Switzerland for fourth straight year   Selexis SA, a JSR Life Sciences company, announced that…

Heidi.news

Heidi.news | The Swiss Confederation reinvests in the development of Swiss vaccines

A CHF 50 million incentive programme   The Swiss Confederation hopes to contribute to making Switzerland a place of research…

Switzerland Global Enterprise

S-GE | The new EU Medical Device Regulation (MDR) came into force on 26 May 2021

Medical devices regulation (MDR): overview   What do exporters need to know about the Medical Devices Regulation (MDR)? The date…

Haya Therapeutics

Haya Therapeutics | Completes CHF 18 mio. seed financing

Anti-fibrotic therapies targeting long non-coding RNAs   HAYA Therapeutics, SA, a company developing precision medicines that target tissue and cell-specific…

CERN

CERN | Innovate in healthcare with CERN

Connecting Life Sciences Innovators (CLSI) event On 18 March, 2021 the Medical Applications section of the CERN Knowledge Transfer (KT)…

Biopôle

Biopôle | New start-up fund to foster early innovation in the Life Sciences

Accelerate the innovation of start-ups established at Biopôle    Biopôle SA, a privately held Swiss not-for-profit organisation that manages and promotes…

EPFL

EPFL | Cancer cells hijack the 3D structure of DNA

A novel algorithmic approach on cancer cells   Scientists at EPFL and UNIL have used a novel algorithmic approach on…

bNovate

bNovate | Fundraising to expand commercial activities internationally

CHF 5 million fundraising bNovate Technologies SA, a Swiss company specialised in industrial microbiology aiming at increasing the safety of…

Flowbone

Flowbone | Winner of the 2nd round of the Venture Kick competition

Prize of CHF 50’000   EPFL scientists have developed a gel that can locally reinforce bones weakened by osteoporosis. The scientists…

Lonza

Lonza | Invests CHF 650 million in Visp

Significant investments to expand its mammalian drug substance manufacturing facilities in Visp The Lonza‘s expansion in Visp (Valais, Switzerland) will…

Swiss Biotech Center

Swiss Biotech Center | Covid-19: a 2nd generation vaccine in preparation in Monthey

Strategic collaboration agreement between Swiss Biotech Center & Berna Biotech Pharma The Swiss biotech companies Berna Biotech Pharma Gmbh and…

Alithea Genomics

Alithea Genomics | Has been awarded CHF 150,000

CHF 150,000 for RNA sequencing to boost biomedical research Lausanne-based Alithea Genomics, developing a novel technology that enables a high…

Debiopharm

Debiopharm | Launch of the “Innovation DEbiopharm Academia Léman” (IDEAL)

The Lemanic region as a hub for Life Science innovation   Debiopharm a Swiss biopharmaceutical company based in Lausanne, announced the…

Calciscon

Calciscon | Raised CHF 2.5M Series A

Commercialisation of the T50 Test to drive more efficient therapies for renal patients    Calciscon AG announced  the closing for…

Gondola Medical Technologies

Gondola Medical Technologies | New research momentum

Building clinical research momentum with 500’000 CHF Tech Growth loan Clinical research and studies demonstrate Gondola Medical Technologies AMPS therapy’s…

EPFL

EPFL | New “brain stress test” for evaluating the mental status of patients with Parkinson’s disease

Awakening “ghosts” in patients with Parkinson’s   EPFL scientists are developing a completely new “brain stress test” for evaluating the…

HCK

Healthcare Konnect (HCK) | Distribution agreement signed with VUNO

Introduction of AI suite in Swiss medical institutions   South Korean Medical AI trailblazer, VUNO, and Swiss medical distribution company,…

Biopôle

Biopôle | Neurotechnologies offer new hope for patients with Parkinson’s disease

3 Biopôle-based companies are striving to find innovation solutions   CHUV-NeuroTech, ND BioSciences & Gondola Medical Technologies , 3 Biopôle-based companies are…

Mybiopassport

CoreMedica Europe | Intercantonal collaboration on SARS-COV-2 detection in saliva 

Partnership on the analysis of SARS-COV-2 virus in saliva using the RT-PCR method   CoreMedica Europe a Swiss biotechnology company based…

HEIG VD

HEIG – VD | Innovations in health care

A brand new tool is available to map the organisational impacts    Innovation in health care is shaking up and…

ADC Therapeutics

ADC Therapeutics | FDA Approval of ZYNLONTA™

FDA Approval of ZYNLONTA™ in Relapsed or Refractory Diffuse Large B-Cell Lymphoma   ADC Therapeutics SA announced that the Food…

Swiss Biotech Association

Swiss Biotech Association | Record year for Western Switzerland’s biotech industry

An attractive, dynamic & ever-growing life sciences ecosystem   Biotechnology companies based in Switzerland have experienced record investments in the…

EPFL

EPFL | New hydrogel can repair tears in human tissue

An injectable gel that can attach to various kinds of soft internal tissues    EPFL scientists have developed an injectable…

Ferring

Ferring Pharmaceuticals | Ferring Biologics Innovation Centre opens at Biopôle

A new hub for biologics R&D in Western Switzerland   On 1 April 2021, the research-driven biopharmaceutical group Ferring Pharmaceuticals…

GGBa

GGBa | 85 new foreign companies in Western Switzerland in 2020

In 2020, 85 new foreign companies set up shop in Western Switzerland, supported by Greater Geneva Bern area (GGBa) and the…

Lonza

Lonza | Hiring of 1200 people in Visp

Lonza, the Valais-based company, is hiring of 1200 people for its plant in Visp (Valais, Switzerland), 650 have already been…

Swiss Institute of Bioinformatics (SIB)

SIB | Discover the SIB Remarkable Outputs 2020

Discover 10 Remarkable Outputs of 2020, brought to you by scientists from the SIB Swiss Institute of Bioinformatics, across Switzerland.

CSEM

CSEM | 2020 Digital Journey Award

Gait Up & Definition12 win the 2020 CSEM digital journey award   CSEM has announced the two winners of its…

SIB Swiss Bioinformatics Institute

SIB | Creation of a Swiss SARS-CoV-2 Data Hub 

Accelerating global COVID-19 research with a Swiss SARS-CoV-2 Data Hub  Over the past weeks and with the threat of emerging…

Inait

Inait | Joined the Scale Up Vaud program

Artificial Brain Intelligence (ABI)   An annual label created in 2016, Scale Up Vaud helps the CEOs of high-growth Vaud…

Netsensing Technology

Netsensing Technology | SmartEEs2 (EU H2020) contracting phase

The EU consortium will reinforce its penetration to global market & its position with EU partners   Incubated at Microcity,…

Terapet

Terapet | Proton therapy

CHF 1.5M of non-dilutive funding   Terapet SA, a privately held Swiss MedTech company developing innovative solutions for a safer,…

Adiposs

Adiposs | Green light for clinical trials

ImageBAT   Following the scientific advice meeting with The Medicines and Healthcare products Regulatory Agency in the UK,  the Geneva…

CHUV HUG EPFL

CHUV, EPFL, HUG | AI now sees & hears COVID in your lungs

Deep learning algorithms automating the prediction of diagnosis & outcome of Covid-19 from chest images and breath sounds   DeepChest…

Asceneuron

Asceneuron SA | Awarded by the Alzheimer’s Drug Discovery Foundation

Asceneuron Receives USD 2.2 Million Award from the Alzheimer’s Drug Discovery Foundation. Award will fund first in human clinical trials of next generation O-GlcNAcase inhibitor, ASN51, to start Q2 2021

Biopôle

Biopôle | Hosts the 1st branch of Superlab Suisse

The centre will open by the end of the 2nd quarter of 2021   Superlab Suisse AG, a Zurich-based private…

EBAMed

EBAMed | Swiss-based medtech startup

New CEO   EBAMed SA, developer of medical technologies to transform the treatment of cardiac arrhythmias, has appointed experienced specialist…

Biopôle

Biopôle | 3 new buildings by 2024

Life Sciences cluster   The Biopôle site continues its strong development with the construction of three new buildings. By 2024,…

Canton Neuchâtel

New training course: chemical & pharmaceutical production technologist

Close collaboration between biopharmaceutical companies & Canton de Neuchâtel   The Canton of Neuchâtel will open up a new dual-mode training route…

Universität Bern

Bern Center for Artificial Intelligence in Medicine (CAIM)

A new platform in the field of Artificial Intelligence in medicine   The University of Bern & the Inselspital, Bern…

Universität Bern

Multidisciplinary Center for Infectious Diseases & Immunity (MCIDI)

Newly founded: MCIDI   The University of Bern established a multidisciplinary center to study the origin and course of infectious…

Zeta

ZETA | A new subsidiary in Switzerland (Visp, VS)

Switzerland is the Mecca of the pharmaceutical industry   ZETA, the engineering specialist for the pharmaceutical and biotech industries, manages…

Distalmotion

Distalmotion | Received European CE mark for Dexter surgical robot

Dexter surgical robot  Distalmotion, a Swiss-based medical device company establishing a new global standard of care ensuring every patient can…

Debiopharm

Debiopharm | Phase II research against covid-19 launched

Antiviral Alisporivir: a valuable additional therapy to SOC   Debiopharm, a Swiss biopharmaceutical company, announced the first patient dosed in…

ADR-AC | A new testing service against the new Coronavirus 2019

ADR-AC GmbH, Bern launches a laboratory analysis test service for memory T cells against the novel 2019 Coronavirus

Swiss Medtech

Swiss Medtech | Award 2021

Call for entries 2021 marks the 4th year that the Swiss Medtech Award recognises outstanding achievements in the Swiss medical…

EPFL

EPFL | New synthetic molecule to kill the flu virus

EPFL scientists have developed a synthetic molecule capable of killing the virus that causes influenza. They hope their discovery will…

EspeRare Pierre Fabre

EspeRare & Pierre Fabre | A pioneering treatment for XLHED

Co-develop the ER-004 treatment   The EspeRare Foundation and Pierre Fabre join forces to develop and market a pioneering treatment…

Comphya

Comphya | Raised additional USD 1.3 million

Additional USD 1.3 million to secure the execution of the pilot clinical trials to start early 2021   One year…

ABCDx

ABCDx | Submit StrokeCheck for clearance in the US & EU

Targeting launches in the US & EU: 2021   Swiss diagnostics firm ABCDx is developing a point-of-care blood test for…

Lymphatica

Lymphatica Medtech | Raises seven-digit Series A round

LymphoDRAIN product: advance in clinical trials & improve the usability and digitisation   LYMPHATICA Medtech, a vascular medical device development…

SICHH

SICHH | BrainFit4Life project

The new SICHH symposium series is supported by Innosuisse    The Swiss Integrative Center for Human Health (SICHH) is supported…

Biopôle CSL Behring

CSL BEHRING REI & BIOPÔLE | A new collaboration partnership

New opportunities in R&D and technology development   The CSL Behring Research External Innovation (REI) team in Europe & Biopôle…

Abionic

Abionic | Five-minutes test for scoring COVID-19 severity

The 1st COVID-19 severity score facilitating patient triage   Abionic launched a 5-minutes test for scoring COVID-19 severity. This test…

HESAV Campus Santé

HESAV | A new Campus dedicated to Health

A Campus for new synergies   Consisting of three main buildings, the campus will be a training centre for health…

SEED Biosciences

SEED Biosciences | Completes CHF 1 mio. series A financing round

New private investor   Life-sciences startup SEED Biosciences raised CHF 1 million in a Series A fundraising round. The capital…

Eyeware

Startup Eyeware | Products available all the way to Japan!

Eyeware has just entered into a partnership with the company Studio Uni    The startup Eyeware, hosted at IdeArk in…